Desmoid tumours treated with triphenylethylenes.

[1]  M. Sporn,et al.  Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. , 1990, British Journal of Cancer.

[2]  S. Ebbs,et al.  Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communication. , 1990, Journal of steroid biochemistry.

[3]  R. Peto,et al.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. , 1989, The New England journal of medicine.

[4]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[5]  B. Shmookler,et al.  Estrogen receptor protein in bone and soft tissue tumors. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[6]  K. Kiel,et al.  Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors) , 1984 .

[7]  C. J. Rosenthal,et al.  Remission of rapidly growing desmoid tumors after tamoxifen therapy , 1983, Cancer.

[8]  W. Waddell,et al.  Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach , 1983, Journal of surgical oncology.

[9]  C. Beattie,et al.  Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin. , 1980, Cancer research.

[10]  M. Canlas,et al.  Desmoid tumor and laparotomy scars. , 1973, International surgery.

[11]  Jack Cuzick,et al.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .